Formulation studies on topical preparations of clonazepam

S.T.P. Pharma Sciences

Volumn 7, Issue 2, 1997, Pages 229-234

  Mura, P ^a   Faucci, M T ^a   Corti, P ^a   Bramanti, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

artificial membrane; Clonazepam; enhancing activity; Topical semisolidformulations carbopol

Indexed keywords

2 PROPANOL; CLONAZEPAM;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TRANSPORT; TRANSDERMAL DRUG ADMINISTRATION; TRANSPORT KINETICS; VISCOSITY;

EID: 0031544830     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. KYDONIEUS A.F. Fundamentals of transdermal drug delivery. In : Transdermal Drug Delivery, A.F. Kydonieus and B. Berner Eds, CRC Press, Boca Raton, 1987, pp. 46.
2. WALTERS K.A. Percutaneous absorption and transdermal therapy. Pharm. Technol, 10, 3044,1986.
3. WALTERS K.A. Penetration enhancers and their use in transdermal therapeutic systems. In : Transdermal Drug Delivery, J. Hadgraftand R.H. Guy Eds, Marcel Dekker, New York, 1989, pp. 197233.
4. MURA P, LIGUORI A, BRAMANTIG, CORTI P, MURRATZU C. and CELESTI L. In vitro study of clonazepam diffusion kinetics from solutions or hydrophilic gel. Pharm. Acta Helv, 11,298303, 1990.
5. MURA P, BETTINETTI O.P, LIGUORI A, BRAMANTI G, CORTI P. and MURRATZU C. Formulation factors influencing the release of clonazepam from a Carbopol hydrogel. Boll. Chim. Farm, 11, 326331 1989.
6. MURA P, CELESTI L, VALOTI M, SANTONI G. and CORTI P. The singlepass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. III. Influence of vehicle composition on drug permeation. Eur. J. Pharm. Biopharm, ' 40,9095,1994.
7. LEUNG S.S, ROBINSON J.R. and LEE V.H. Parenteral products. In : Controlled Drug Delivery, 2nd Ed, J.R. Robinson and V.H. Lee Eds, Marcel Dekker, New York, 1987, pp. 452454.
8. ARMSTRONG N.A, GRIFFITHS H.A and JAMES K.C. An in vitro model to simulate drug release from oily media. Int. J. Pharm, 41, 115119, 1988.
9. SCHEUPLEIN R.J. and BLANK I.H. Permeability of the skin. Physiol. Rev, 51, 702747, 1971.
10. HIGUCHI T. Rate of release of medicaments from ointment bases containing drug in suspension. J. Pharm. Sci, 50,874875, 1961.
11. RITSCHELW.A.andSPROCKELO.L.Sorption promotersfor topically applied substances. Drugs of Today, 24, 613628, 1988.
12. PFISTER W. R. and HSIEH D.S.T. Permeation enhancers compatible with transdermal drug delivery systems. I. Selection and formulation considerations. Pharm. Technol, 14, 132140, 1990.
13. BARRY B.W. Transdermal Drug Delivery. In : Drug Delivery Systems, Fundamentals and Techniques, P. Johnson and J.G. LloydJones Eds, Ellis Horwood Ltd, Chichester, 1987, pp. 203210.
14. CELESTI L, MURRATZU C, VALOTI M, SGARAGLI P. and CORTI P. The singlepass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. I. General characteristics. Meth. Find. Exp. Clin. Pharmacol, 14, 701709, 1992.
15. CELESTI L, MURRATZU C, VALOTI M, SGARAGLI P. and CORTI P. The singlepass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. II. Influence of hydrogelborne propylene glycol and skin pretreatment with lauryl alcohol. Meth. Find. Exp. Clin. Pharmacol, 15, 4956, 1993.